Prevalence of Nonalcoholic Fatty Liver Disease in Hypothyroid Subjects: A Cross-sectional Comparative Study

被引:2
作者
Patel, Maharshi [1 ]
Acharya, Sourya [1 ]
Kumar, Sunil [1 ]
机构
[1] Datta Meghe Inst Higher Educ & Res Univ, Dept Med, Jawaharlal Nehru Med Coll, Wardha, Maharashtra, India
关键词
Nonalcoholic fatty liver disease; overt hypothyroid; subclinical hypothyroid; THYROID-FUNCTION;
D O I
10.4103/injms.injms_24_23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. NAFLD has become the leading cause of liver disease globally. Hypothyroidism is a major factor in the development of NAFLD. Thus, the current investigation aimed to estimate the prevalence of NAFLD in individuals with hypothyroidism. Materials and Methods: This cross-sectional comparative study was conducted on 142 patients who qualified for the eligibility criteria. Proper history, examination, anthropometric measurements, and biochemical parameters were estimated. The collected data were entered in Excel and analyzed using the Statistical Package for Social Science 25 version developed by IBM (International Business Machine), IBM is a USA based company and the Student's t-test and the Chi-square test were applied. Results: In this study, 12.6% of the treated subjects had fatty liver and 59.15% of the untreated subjects had fatty liver. From these untreated cases, fatty liver was found in 17.6% of subclinical hypothyroid subjects and 41.5% of overt hypothyroid subjects. There was a significant association between thyroid status and fatty liver (chi(2) = 68.046, P < 0.001). Conclusions: We have found that NAFLD is more prevalent in untreated hypothyroid subjects. The severity of NAFLD is more in patients with overt hypothyroidism. Early treatment with thyroxine can prevent the progression of the fatty liver and grave consequences such as nonalcoholic steatohepatitis and cirrhosis.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 23 条
[1]  
Alhussainy F, 2018, Int J Community Med Public Health, V5, P2616
[2]   Thyroid Dysfunction at Different Stages of Chronic Kidney Disease: A Cross-Sectional Study at a Rural Teaching College in Central India [J].
Ansari, Ifthekar ;
Kumar, Sunil ;
Acharya, Sourya ;
Agrawal, Sachin ;
Saboo, Keyur .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
[3]  
Beralkar A, 2018, J. Evid. Based Med. Healthc, V5, P3539
[4]   Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study [J].
Chaker, Layal ;
Ligthart, Symen ;
Korevaar, Tim I. M. ;
Hofman, Albert ;
Franco, Oscar H. ;
Peeters, Robin P. ;
Dehghan, Abbas .
BMC MEDICINE, 2016, 14
[5]  
Mazo Daniel Ferraz de Campos, 2011, Arq. Gastroenterol., V48, P186
[6]   Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among metabolic syndrome parameters [J].
Erdogan, M. ;
Canataroglu, A. ;
Ganidagli, S. ;
Kulaksizoglu, M. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (07) :488-492
[7]  
Gaitonde DY, 2012, AM FAM PHYSICIAN, V86, P244
[8]  
Gupta A., 2019, JK Science, V20, P161
[9]   Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis [J].
He, Weiwei ;
An, Xiaofei ;
Li, Ling ;
Shao, Xiaoqing ;
Li, Qian ;
Yao, Qiuming ;
Zhang, Jin-an .
FRONTIERS IN ENDOCRINOLOGY, 2017, 8
[10]   Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):: National Health and Nutrition Examination Survey (NHANES III) [J].
Hollowell, JG ;
Staehling, NW ;
Flanders, WD ;
Hannon, WH ;
Gunter, EW ;
Spencer, CA ;
Braverman, LE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :489-499